You're all set! 🎉

Thanks for subscribing. Your plan is now active and every feature on it is unlocked. We've also sent a confirmation to your email.

Thanks for subscribing. Your plan is now active and every feature on it is unlocked. We've also sent a confirmation to your email.

IMVT

Immunovant, Inc.

Manufacturing

Pharmaceutical Products

XNAS

38.90

-1.19

-2.97%

Jul 28, 3:59 PM EDT

O 40.09H 38.97L 38.63C 38.875Vol 708.46K

Jul 28, 2026

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases.

Sector

Manufacturing

Theme

Unknown theme

Industry

Pharmaceutical Products

Date listed

Fri, Jun 21, 2019

Employees

Currency

usd

Shares outstanding

Locale

Shares float

Type

Market cap.

P/E (realtime)

Primary exchange

XNAS

CIK

0001764013

Website

No recent news for IMVT